Skip to content
    Colt Ventures logo

    Colt Ventures

    Dallas, Texas, United StatesFounded 2003
    www.coltventures.comLinkedIn
    Biotech & Life SciencesClimate & EnergyConsumerE-Commerce & MarketplaceFintechPropTechInfrastructure & CloudManufacturing

    Colt Ventures is a diversified family office founded in 2003 by Darren Blanton, headquartered in Dallas, TX. The firm invests personal capital across private and public markets, with sector focus including biotechnology, oil & gas, technology, real estate, consumer & retail, financial services, and special situations.

    69% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (62% of deals). Average disclosed round size is $108.9M (across 11 rounds with reported amounts).

    Find people at Colt Ventures on Goldilocks AI

    Portfolio

    7

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    0

    Team

    DB

    Darren Blanton

    Founder and Managing Partner

    BL

    Brian Liu

    Associate

    JS

    Jivana Shukla

    Associate

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    13 investments
    CompanyRoundAmountDate
    Alterome Therapeutics logoAlterome TherapeuticsSeries B$35MApr 2024
    AAlteromeSeries B$132MApr 2024
    Alterome Therapeutics logoAlterome TherapeuticsSeries B$132MJan 2024
    Odyssey Therapeutics logoOdyssey TherapeuticsSeries B$168MOct 2022
    Alterome Therapeutics logoAlterome TherapeuticsSeries A$64MJan 2022
    Odyssey Therapeutics logoOdyssey TherapeuticsUnknown$168MJan 2022
    Odyssey Therapeutics logoOdyssey TherapeuticsSeries A$218MDec 2021
    Rumble logoRumbleSeries B—May 2021
    ReCode Therapeutics logoReCode TherapeuticsSeries B$50MJan 2021
    RReCodeSeries B$50MJan 2021
    SSilverback TherapeuticsSeries B—Jan 2020
    ReCode Therapeutics logoReCode TherapeuticsSeries A$80M—
    Odyssey Therapeutics logoOdyssey TherapeuticsSeries C$101M—

    Top Co-Investors

    OrbiMed12 shared
    Nextech Invest Ltd.5 shared
    Fidelity Management & Research Company4 shared
    Alexandria Venture Investments4 shared
    SR One4 shared
    General Catalyst4 shared
    Foresite Capital4 shared
    HBM Healthcare Investments4 shared
    Boxer Capital4 shared
    Canaan Partners4 shared
    Catalio Capital Management3 shared
    Logos Capital3 shared
    Blue Owl Capital3 shared
    Goldman Sachs Alternatives3 shared
    The Invus Group, LLC3 shared
    Digitalis Ventures3 shared
    Woodline Partners LP2 shared
    T. Rowe Price2 shared
    Walleye Capital2 shared
    Correlation Ventures2 shared

    Last updated: 20 October 2026